The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Chlorophyllin intervention reduces aflatoxin–DNA adducts in individuals at high risk for liver cancer
Open accessAbstract
Residents of Qidong, People's Republic of China, are at high risk for development of hepatocellular carcinoma, in part from consumption of foods contaminated with aflatoxins. Chlorophyllin, a mixture of semisynthetic, water-soluble derivatives of chlorophyll that is used as a food colorant and over-the-counter medicine, has been shown to be an effective inhibitor of aflatoxin hepatocarcinogenesis in animal models by blocking carcinogen bioavailability. In a randomized, double-blind, placebo-controlled chemoprevention trial, we tested whether chlorophyllin could alter the disposition of aflatoxin. One hundred and eighty healthy adults from Qidong were randomly assigned to ingest 100 mg of chlorophyllin or a placebo three times a day for 4 months. The primary endpoint was modulation of levels of aflatoxin-N 7 -guanine adducts in urine samples collected 3 months into the intervention measured by using sequential immunoaffinity chromatography and liquid chromatography–electrospray mass spectrometry. This aflatoxin–DNA adduct excretion product serves as a biomarker of the biologically effective dose of aflatoxin, and elevated levels are associated with increased risk of liver cancer. Adherence to the study protocol was outstanding, and no adverse events were reported. Aflatoxin-N 7 -guanine could be detected in 105 of 169 available samples. Chlorophyllin consumption at each meal led to an overall 55% reduction ( P = 0.036) in median urinary levels of this aflatoxin biomarker compared with those taking placebo. Thus, prophylactic interventions with chlorophyllin or supplementation of diets with foods rich in chlorophylls may represent practical means to prevent the development of hepatocellular carcinoma or other environmentally induced cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chang, M.-H., Chen, C.-J., Lai, M.-S., Hsu, H.-M., Wu, T.-C., Kong, M.-S., Liang, D.-C., Shau, W.-Y., & Chen, D.-S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706263362602 · Cited by 1,883
A mutator phenotype in cancer.
Loeb, L. A. (2001) · PubMed · Cited by 781
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma
Ross, R. K., Yu, M. C., Henderson, B. E., Yuan, J.-M., Qian, G.-S., Tu, J.-T., Gao, Y.-T., Wogan, G. N., & Groopman, J. D. (1992) · The Lancet · doi:10.1016/0140-6736(92)91528-g · Cited by 725
Self-citationA Mutator Phenotype in Cancer 1
Loeb, L. A. (2001) · Cited by 670
Qian, G.-S., Ross, R. K., Yu, M. C., Yuan, J., Gao, Y. T., Henderson, B. E., Wogan, G. N., & Groopman, J. D. (1994) · PubMed · Cited by 666
Self-citationThe toxicology of aflatoxins: human health, veterinary and agricultural significance.
Eaton, D. L., & Groopman, J. D. (1993) · Cited by 597
Self-citationSomatic point mutations in the p53 gene of human tumors and cell lines: updated compilation
Hollstein, M. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.1.141 · Cited by 499
Primary prevention of hepatocellular carcinoma
YU, S. (1995) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1995.tb01370.x · Cited by 434
Wang, J.-S., Shen, X., He, X., Zhu, Y.-R., Zhang, B.-C., Wang, J.-B., Qian, G.-S., Kuang, S.-Y., Zarba, A., Egner, P. A., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.4.347 · Cited by 307
Self-citationBase substitution mutations induced by metabolically activated aflatoxin B1.
Foster, P. L., Eisenstadt, E., & Miller, J. H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.9.2695 · Cited by 274
Cited by
Rushing, B. R., & Selim, M. I. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.11.047 · Cited by 989
Versantvoort, C. H. M., Oomen, A. G., Van de Kamp, E., Rompelberg, C. J. M., & Sips, A. J. A. M. (2005) · Food and Chemical Toxicology · doi:10.1016/j.fct.2004.08.007 · Cited by 768
Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology
Kensler, T. W., Roebuck, B. D., Wogan, G. N., & Groopman, J. D. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfq283 · Cited by 703
Self-citationNutrition and cancer: A review of the evidence for an anti-cancer diet
Donaldson, M. S. (2004) · Nutrition Journal · doi:10.1186/1475-2891-3-19 · Cited by 699
Digestion, absorption, and cancer preventative activity of dietary chlorophyll derivatives
Ferruzzi, M. G., & Blakeslee, J. (2007) · Nutrition Research · doi:10.1016/j.nutres.2006.12.003 · Cited by 524
Metadata
- Authors
- Egner, P. A., Wang, J.-B., Zhu, Y.-R., Zhang, B.-C., Wu, Y., Zhang, Q.-N., Qian, G.-S., Kuang, S.-Y., Gange, S. J., Jacobson, L. P., Helzlsouer, K. J., Bailey, G. S., Groopman, J. D., & Kensler, T. W.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2001-11-27
- Volume
- 98
- Issue
- 25
- Pages
- 14601-14606
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2121934317
- Cited by
- 301
- References
- 25
- FWCI
- 14.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chlorophyllin intervention reduces aflatoxin–DNA adducts in individuals at high risk for liver cancer. https://app.cochat.ai/papers/10.1073/pnas.251536898
- The paper
- Egner, P. A., Wang, J.-B., Zhu, Y.-R., Zhang, B.-C., Wu, Y., Zhang, Q.-N., Qian, G.-S., Kuang, S.-Y., Gange, S. J., Jacobson, L. P., Helzlsouer, K. J., Bailey, G. S., Groopman, J. D., & Kensler, T. W. (2001). Chlorophyllin intervention reduces aflatoxin–DNA adducts in individuals at high risk for liver cancer. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.251536898
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.